Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Multi-Center, Randomized, Double-Blind, Controlled Trial Evaluating the Safety and Efficacy of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)

NCT06422884 is registered in ClinicalTrials.gov with Endeavor Biomedicines, Inc. as lead sponsor.

NCT NCT06422884
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06422884 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Multi-Center, Randomized, Double-Blind, Controlled Trial Evaluating the Safety and Efficacy of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)
Lead sponsor
Endeavor Biomedicines, Inc.
Phase
Phase 2
Overall status
Active, not recruiting
Start date
November 15, 2024
Completion date
October 31, 2026
Enrollment
213 (actual)
Sites
78

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic pulmonary fibrosis, progressive fibrosing interstitial lung disease